Aemetis (AMTX) Rating Lowered to Sell at Zacks Investment Research

Aemetis (NASDAQ:AMTX) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a report released on Tuesday.

According to Zacks, “Aemetis, Inc. is an advanced fuels and renewable chemicals company. It produces renewable chemicals and fuels using patented microbes and processes. Aemetis owns and operates an ethanol animal feed plant in California to produce D5 Advanced Biofuels using the sorghum/biogas/CHP pathway. The Company also built, owns, and operates a renewable chemicals and advanced fuels production facility on the East Coast of India producing high quality, distilled biodiesel and refined glycerin for customers in Europe and Asia. Aemetis, Inc. is headquartered in Cupertino, California. “

Separately, B. Riley restated a “hold” rating and set a $2.00 price target on shares of Aemetis in a research report on Monday, November 13th.

Aemetis (NASDAQ:AMTX) opened at $0.57 on Tuesday. The company has a quick ratio of 0.20, a current ratio of 0.37 and a debt-to-equity ratio of -1.87. Aemetis has a 1 year low of $0.51 and a 1 year high of $2.50.

A hedge fund recently bought a new stake in Aemetis stock. Ninepoint Partners LP acquired a new stake in shares of Aemetis Inc (NASDAQ:AMTX) in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 1,151,373 shares of the specialty chemicals company’s stock, valued at approximately $1,002,000. Ninepoint Partners LP owned about 5.81% of Aemetis at the end of the most recent quarter. 17.73% of the stock is currently owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION WARNING: This piece was published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this piece on another website, it was illegally copied and reposted in violation of United States and international copyright & trademark laws. The original version of this piece can be accessed at https://www.dispatchtribunal.com/2018/01/04/aemetis-amtx-rating-lowered-to-sell-at-zacks-investment-research.html.

About Aemetis

Aemetis, Inc is an international renewable fuels and biochemicals company. The Company is focused on the production of fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products by conversion of first-generation ethanol and biodiesel plants into biorefineries.

Receive News & Ratings for Aemetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aemetis and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply